Barriers to and strategies to address COVID-19 testing hesitancy: a rapid scoping review
Authors:
- Mark EmbrettMEMark Embrett
- S. Meaghan SimSSS. Meaghan Sim
- Hilary A. T. CaldwellHCHilary A. T. Caldwell
- Leah BoulosLBLeah Boulos
- Ziwa YuZYZiwa Yu
- Gina AgarwalGAGina Agarwal
- Rhiannon CooperRCRhiannon Cooper
- Allyson J. Gallant AjAAAllyson J. Gallant Aj
- Iwona A. BielskaIBIwona A. Bielska
- Jawad ChishtieJCJawad Chishtie
- Janet CurranJCJanet Curran
Top Cited Papers
Open Access
- 14 April 2022
- journal article
- review article
- Published by Springer Nature in BMC Public Health
- Vol. 22 (1) , 1-10
Abstract
Background: Testing is a foundational component of any COVID-19 management strategy; however, emerging evidence suggests that barriers and hesitancy to COVID-19 testing may affect uptake or participation and often these are multiple and intersecting factors that may vary across population groups. To this end, Health Canada’s COVID-19 Testing and Screening Expert Advisory Panel commissioned this rapid review in January 2021 to explore the available evidence in this area. The aim of this rapid review was to identify barriers to COVID-19 testing and strategies used to mitigate these barriers. Methods: Searches (completed January 8, 2021) were conducted in MEDLINE, Scopus, medRxiv/bioRxiv, Cochrane and online grey literature sources to identify publications that described barriers and strategies related to COVID-19 testing. Results: From 1294 academic and 97 grey literature search results, 31 academic and 31 grey literature sources were included. Data were extracted from the relevant papers. The most cited barriers were cost of testing; low health literacy; low trust in the healthcare system; availability and accessibility of testing sites; and stigma and consequences of testing positive. Strategies to mitigate barriers to COVID-19 testing included: free testing; promoting awareness of importance to testing; presenting various testing options and types of testing centres (i.e., drive-thru, walk-up, home testing); providing transportation to testing centres; and offering support for self-isolation (e.g., salary support or housing). Conclusion: Various barriers to COVID-19 testing and strategies for mitigating these barriers were identified. Further research to test the efficacy of these strategies is needed to better support testing for COVID-19 by addressing testing hesitancy as part of the broader COVID-19 public health response.Keywords
All Related Versions
This publication has 41 references indexed in Scilit:
- How to link patients with suspicious COVID-19 to health system from the community pharmacies? A route proposalResearch in Social and Administrative Pharmacy, 2021
- Psychogenic stress in hospitalized veterinary patients: Causation, implications, and therapiesJournal of Veterinary Emergency and Critical Care, 2019
- Using rapid reviews to strengthen health policy and systems and progress towards universal health coverageBMJ Global Health, 2019
- PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and ExplanationAnnals of Internal Medicine, 2018
- Pathways to Educational Success Among Refugees: Connecting Locally and Globally Situated ResourcesAmerican Educational Research Journal, 2017
- Barriers of Influenza Vaccination Intention and Behavior – A Systematic Review of Influenza Vaccine Hesitancy, 2005 – 2016PLOS ONE, 2017
- Nursing supervision: challenges and opportunities for successLearning Disability Practice, 2016
- A “three delays” model for severe sepsis in resource-limited countriesJournal of Critical Care, 2015
- Health literacy as a public health goal: a challenge for contemporary health education and communication strategies into the 21st centuryHealth Promotion International, 2000
- Determinants of Three Stages of Delay in Seeking Care at a Medical ClinicMedical Care, 1979